| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||
Net loss | ||||||
-13,731 | -12,025 | -8,932 | -6,572 | -7,891 | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Loss on sale of discontinued operations | ||||||
-210 | 0 | 0 | - | -38 | ||
Depreciation and amortization | ||||||
4,671 | 2,892 | 2,405 | 1,902 | 1,854 | ||
Stock-based compensation | ||||||
2,603 | 3,185 | 3,478 | 1,251 | 1,229 | ||
Research and development fee obligation | ||||||
- | - | - | 889 | 0 | ||
Changes in certain current assets and liabilities: | ||||||
Accounts receivable - trade | ||||||
5,820 | 3,801 | 1,505 | 280 | 1,047 | ||
Inventories | ||||||
9,767 | 4,801 | 4,410 | - | - | ||
Prepaid expenses and other current assets | ||||||
137 | 425 | 598 | 11 | -30 | ||
Accounts payable - trade | ||||||
2,401 | -1,524 | 1,952 | 1,544 | 1,354 | ||
Accrued expenses and other liabilities | ||||||
1,946 | 947 | 258 | 1,675 | 810 | ||
Research and development fee obligation | ||||||
- | - | - | 628 | 541 | ||
Other | ||||||
1 | 31 | -135 | 0 | 0 | ||
Net cash used in operating activities - continuing operations | ||||||
-17,625 | -15,583 | -7,217 | - | - | ||
Net cash used by operating activities - discontinued operations | ||||||
-144 | 0 | 0 | - | - | ||
Net cash used in operating activities | ||||||
-17,769 | -15,583 | -7,217 | -1,119 | -892 | ||
INVESTING ACTIVITIES | ||||||
Acquisition of Telos, net of cash acquired | ||||||
49,836 | 0 | 0 | - | - | ||
Purchase of notes receivable | ||||||
0 | 502 | 0 | 0 | - | ||
Proceeds from assets held for sale | ||||||
- | - | - | - | 539 | ||
Purchases of licenses | ||||||
270 | 210 | 1,337 | 406 | 41 | ||
Purchases of property and equipment | ||||||
11,816 | 5,253 | 5,207 | 4,348 | 2,211 | ||
Net cash used in investing activities | ||||||
-61,922 | -5,965 | -6,544 | -4,754 | -1,713 | ||
FINANCING ACTIVITIES | ||||||
Payments on mortgage notes | ||||||
- | - | - | 102 | 98 | ||
Proceeds from issuance of debt with affiliate | ||||||
30,000 | 0 | 7,992 | 4,500 | 0 | ||
Repayments of Lines of Credit | ||||||
0 | 4,065 | 0 | - | - | ||
Payments on note with affiliate | ||||||
- | - | - | 0 | - | ||
Proceeds from issuance of common stock, net of issuance costs | ||||||
59,996 | 43,425 | 53,775 | 0 | 0 | ||
Payment of preferred stock dividends | ||||||
0 | 0 | 5,965 | 0 | 0 | ||
Proceeds from exercise of stock options | ||||||
1,141 | 410 | 0 | 0 | - | ||
Shares surrendered by employees to pay taxes on restricted shares | ||||||
0 | 0 | 990 | 0 | 0 | ||
Repayments of Notes Payable | ||||||
118 | 113 | 78 | - | - | ||
Payments of deferred offering costs | ||||||
- | - | - | 794 | 0 | ||
Net cash (used in) provided by financing activities | ||||||
91,019 | 39,657 | 54,734 | 3,604 | -98 | ||
Effect of exchange rate changes on cash | ||||||
8 | 0 | 0 | - | - | ||
NET DECREASE IN CASH | ||||||
11,336 | 18,109 | 40,973 | -2,269 | -2,703 | ||
SUPPLEMENTAL DISCLOSURES | ||||||
Cash paid for interest | ||||||
4,229 | 2,255 | 2,490 | 1,476 | 1,230 | ||
Accretion of redeemable convertible preferred stock | ||||||
0 | 0 | 4,563 | 5,876 | 4,797 | ||
Transfer of instruments from property and equipment to inventory | ||||||
1,037 | 362 | 1,249 | 1,225 | 474 | ||
Issuance of common shares to acquire Telos | ||||||
10,000 | 0 | 0 | - | - | ||
Intellectual property license (See Note 4) | ||||||
12,410 | 0 | 0 | - | - | ||
Divestiture consideration allocated to assets held for sale (See Note 4) | ||||||
12,590 | 0 | 0 | - | - | ||
Payment of Term Note B with revolving credit facility (See Note 8) | ||||||
5,000 | 0 | 0 | - | - | ||
U.S. | ||||||
Inventories | ||||||
- | - | - | 1,029 | - | ||
International | ||||||
Inventories | ||||||
- | - | - | -1,918 | - | ||